PacBio has delivered its first Vega systems to Berry Genomics as part of an early access agreement aimed at developing and optimizing targeted assays for carrier, prenatal, and newborn screening in ...
PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the upcoming availability of SPRQ-Nx chemistry and an accompanying software update for its Vega ...
MENLO PARK, Calif., Aug. 2, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that customer shipments of Onso short-read ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Pacific Biosciences of California (NASDAQ:PACB) reported second-quarter revenue of $39 million, including $20 million in consumables revenue, $13 million in instrument revenue and $6 million in ...
Pacific Biosciences (PacBio) of California said today it has sold 10 Sequel ® System sequencers for an undisclosed price to Annoroad Gene Technology, a provider of genomics services that has disclosed ...
Pacific Biosciences' Q4'24 results were another disappointment, with revenue and margin misses, and 2025 guidance was notably below expectations. Underlying utilization growth (genetic data generated ...
(Reuters) - Gene-sequencing company Pacific BioSciences of California Inc on Tuesday announced the launch of a new, more affordable, higher-throughput "long-read" sequencer as well as customer testing ...
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has begun taking orders for its groundbreaking Kinnex RNA kits, which increase ...
Genomics company Pacific Biosciences of California (NASDAQ:PACB) in Q2 CY2026, with sales falling 1.9% year on year to $39.01 million. Its non-GAAP loss of $0.14 per share was 10.4% below analysts’ ...
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced its first customer shipments of Revio long-read sequencing systems will commence on March 8, 2023. As ...
Zacks Investment Research on MSN
PacBio Q2 earnings meet estimates, revenues miss, 2026 sales view cut
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, reported an adjusted loss per share of 14 cents for the second quarter of 2026, wider than the year-ago adjusted loss of 13 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results